Real-time enrollment status for this advanced endometrial carcinoma clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 6:54 AM UTC
| NCT Number | NCT07198074 |
| Recruiting Status | Recruiting |
| Condition | Advanced Endometrial Carcinoma |
| Phase | PHASE3 |
| Target Enrollment | 255 participants |
| Active Locations | 259 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | August 25, 2026 (3 days ago) |
As of August 28, 2026: Clinical trial NCT07198074 is currently recruiting participants. This phase3 study for advanced endometrial carcinoma is actively seeking new participants at 259 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07198074 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 259 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07198074 was last updated 3 days ago (August 25, 2026). HelloStudys verifies this status automatically.